Cargando…

Zoledronic Acid Is Not Equally Potent on Osteoclasts Generated From Different Individuals

Zoledronic acid is a bisphosphonate commonly used to treat bone diseases such as osteoporosis and cancer‐induced bone disease. Patients exhibit a variable sensitivity to zoledronic acid; the underlying explanation for this remains unclear. The objective of this study was to obtain more knowledge in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Møller, Anaïs M J, Delaisse, Jean‐Marie, Olesen, Jacob B, Bechmann, Troels, Madsen, Jonna S, Søe, Kent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657394/ https://www.ncbi.nlm.nih.gov/pubmed/33210064 http://dx.doi.org/10.1002/jbm4.10412

Ejemplares similares

A variability in response of osteoclasts to zoledronic acid is mediated by smoking-associated modification in the DNA methylome
por: Tan, Qihua, et al.
Publicado: (2023)

Aging and menopause reprogram osteoclast precursors for aggressive bone resorption
por: Møller, Anaïs Marie Julie, et al.
Publicado: (2020)

Fusion Potential of Human Osteoclasts In Vitro Reflects Age, Menopause, and In Vivo Bone Resorption Levels of Their Donors—A Possible Involvement of DC-STAMP
por: Møller, Anaïs M. J., et al.
Publicado: (2020)

Osteoclast Fusion: Time‐Lapse Reveals Involvement of CD47 and Syncytin‐1 at Different Stages of Nuclearity
por: Møller, Anaïs Marie Julie, et al.
Publicado: (2016)

Time-lapse reveals that osteoclasts can move across the bone surface while resorbing
por: Søe, Kent, et al.
Publicado: (2017)

Osteoclast Fusion is Based on Heterogeneity Between Fusion Partners
por: Hobolt-Pedersen, Anne-Sofie, et al.
Publicado: (2014)

Pit- and trench-forming osteoclasts: a distinction that matters
por: Merrild, Ditte MH, et al.
Publicado: (2015)

Osteoclasts’ Ability to Generate Trenches Rather Than Pits Depends on High Levels of Active Cathepsin K and Efficient Clearance of Resorption Products
por: Borggaard, Xenia G., et al.
Publicado: (2020)

Septins are critical regulators of osteoclastic bone resorption
por: Møller, Anaïs M. J., et al.
Publicado: (2018)

The Mechanism Switching the Osteoclast From Short to Long Duration Bone Resorption
por: Delaisse, Jean-Marie, et al.
Publicado: (2021)

Potential of Resveratrol Analogues as Antagonists of Osteoclasts and Promoters of Osteoblasts
por: Kupisiewicz, Katarzyna, et al.
Publicado: (2010)

How zoledronic acid improves osteoporosis by acting on osteoclasts
por: Wang, Biao, et al.
Publicado: (2022)

Minimally effective concentration of zoledronic acid to suppress osteoclasts in vitro
por: Li, Pengfei, et al.
Publicado: (2018)

The Capacity of Magnesium to Induce Osteoclast Differentiation Is Greatly Enhanced by the Presence of Zoledronate
por: Ricchiuto, Silvia, et al.
Publicado: (2023)

Reactive oxygen species are required for zoledronic acid-induced apoptosis in osteoclast precursors and mature osteoclast-like cells
por: Tai, Ta-Wei, et al.
Publicado: (2017)

Osteoclast Fusion: Physiological Regulation of Multinucleation through Heterogeneity—Potential Implications for Drug Sensitivity
por: Søe, Kent
Publicado: (2020)

Zoledronate Enhances Osteocyte-Mediated Osteoclast Differentiation by IL-6/RANKL Axis
por: Kim, Hyung Joon, et al.
Publicado: (2019)

Zoledronate suppressed angiogenesis and osteogenesis by inhibiting osteoclasts formation and secretion of PDGF-BB
por: Gao, Si-yong, et al.
Publicado: (2017)

Spatial Organization of Osteoclastic Coupling Factors and Their Receptors at Human Bone Remodeling Sites
por: Borggaard, Xenia G., et al.
Publicado: (2022)

The Bone Resorption Inhibitors Odanacatib and Alendronate Affect Post-Osteoclastic Events Differently in Ovariectomized Rabbits
por: Jensen, Pia Rosgaard, et al.
Publicado: (2013)

Inhibition Effect of Zoledronate on the Osteoclast Differentiation of RAW264.7 Induced by Titanium Particles
por: Zhao, Wenhan, et al.
Publicado: (2021)

Effect of Denosumab on the Change of Osteoclast Precursors Compared to Zoledronate Treatment in Postmenopausal Women with Osteoporosis
por: Kong, Sung Hye, et al.
Publicado: (2022)

Zoledronic acid prevents disuse osteopenia and augments gene expression of osteoclastic differentiation markers in mice
por: Vegger, Jens Bay, et al.
Publicado: (2018)

Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review
por: Wang, Lianwei, et al.
Publicado: (2020)

First-line treatment with bortezomib rapidly stimulates both osteoblast activity and bone matrix deposition in patients with multiple myeloma, and stimulates osteoblast proliferation and differentiation in vitro
por: Lund, Thomas, et al.
Publicado: (2010)

Zoledronic acid promotes osteoclasts ferroptosis by inhibiting FBXO9-mediated p53 ubiquitination and degradation
por: Qu, Xingzhou, et al.
Publicado: (2021)

Zoledronic acid inhibits osteoclast differentiation and function through the regulation of NF-κB and JNK signalling pathways
por: Huang, Xiao-Lin, et al.
Publicado: (2019)

Matrix Metalloproteinase 9 and Vascular Endothelial Growth Factor Are Essential for Osteoclast Recruitment into Developing Long Bones
por: Engsig, Michael T., et al.
Publicado: (2000)

Prognostic impact of serum levels of EGFR and EGFR ligands in early-stage breast cancer
por: Kjær, Ina Mathilde, et al.
Publicado: (2020)

Dysregulated EGFR pathway in serum in early-stage breast cancer patients: A case control study
por: Kjær, Ina Mathilde, et al.
Publicado: (2020)

Osteosarcoma and Metastasis Associated Bone Degradation—A Tale of Osteoclast and Malignant Cell Cooperativity
por: Nørregaard, Kirstine Sandal, et al.
Publicado: (2021)

Zoledronic Acid in a Mouse Model of Human Fibrous Dysplasia: Ineffectiveness on Tissue Pathology, Formation of “Giant Osteoclasts” and Pathogenetic Implications
por: Corsi, Alessandro, et al.
Publicado: (2020)

SUN-347 Glucagon-like Peptide 1 (GLP-1) Acts Directly On Human Osteoclasts To Increase Differentiation And Bone Resorptive Activity
por: Hansen, Morten Steen, et al.
Publicado: (2020)

Predicting brain metastases of breast cancer based on serum S100B and serum HER2
por: BECHMANN, TROELS, et al.
Publicado: (2013)

An Amphotericin B Derivative Equally Potent to Amphotericin B and with Increased Safety
por: Antillón, Armando, et al.
Publicado: (2016)

The reversal phase of the bone-remodeling cycle: cellular prerequisites for coupling resorption and formation
por: Delaisse, Jean-Marie
Publicado: (2014)

The Alternative Faces of Macrophage Generate Osteoclasts
por: Lampiasi, N., et al.
Publicado: (2016)

The distribution pattern of critically short telomeres in human osteoarthritic knees
por: Harbo, Maria, et al.
Publicado: (2012)

Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells
por: Ubellacker, Jessalyn M., et al.
Publicado: (2017)

Zoledronic Acid-Loaded β-TCP Inhibits Tumor Proliferation and Osteoclast Activation: Development of a Functional Bone Substitute for an Efficient Osteosarcoma Treatment
por: Kameda, Yuka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_967l29e9qjvf39k96ima9j12iq